CIK 0001396814 · Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510619477
- Phone
- 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- 4 Open-market sale Chief Financial Officer sold 2,516 shares at $61.37 ($154,417)
- 4 Open-market sale President, Rest of World sold 5,250 shares at an average $61.66 ($323,737)
- 4 Open-market sale Chief Technical Officer sold 7,750 shares at an average $60.38 ($467,961)
- 4 Grant or award Director acquired 1,160 shares (grant or award)
- 4 Open-market sale Chief Lgl & Compliance Officer sold 5,550 shares at an average $60.79 ($337,368)
- 4 Open-market sale Chief Customer Officer sold 2,140 shares at $61.37 ($131,340)
- 4 Grant or award Director acquired 1,160 shares (grant or award)
- 4 Grant or award Director acquired 1,160 shares (grant or award)
- 4 Grant or award Director acquired 1,160 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 1,106 shares at $61.37 ($67,880)
- 4 Grant or award Director acquired 1,160 shares (grant or award)
- 4 Grant or award Director acquired 1,160 shares (grant or award)
- 4 Grant or award Director acquired 1,160 shares (grant or award)
- 4 Option exercise Chief Clinical Officer acquired 2,000 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 1,000 shares at $59.37 ($59,370)
- 4 Option exercise CEO and Chairman acquired 22,500 shares (option exercise)
- 4 Open-market sale President, Rest of World sold 9,824 shares at $73.25 ($719,647)
- 4 Open-market sale President, Rest of World sold 28,026 shares at an average $73.27 ($2,053,491)
- 4 Open-market sale Chief Lgl & Compliance Officer sold 22,500 shares at an average $76.42 ($1,719,393)
Page 9 of 35 · 695 filings